Salt intake linked to gut inflammation in Crohn's patients
NCT ID NCT07169123
First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This study looks at how eating salt affects gut health in people with Crohn's disease. Researchers will track salt intake and measure gut inflammation in 300 participants. The goal is to understand if a high-salt diet worsens symptoms and to improve dietary advice for managing the disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better, personalized diet recommendations for people with Crohn's disease to help manage their condition.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Sep 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with a diagnosis of Crohn's disease followed at McMaster University's Gastroenterology Outpatient Clinic.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 and 70 years of age * Crohn's disease diagnosis * Willing and able to sign written informed consent prior to study entry * Able to comply with the study procedures, in the opinion of the investigator Exclusion Criteria: * Antibiotics, antibacterial agents, or probiotics, currently, or within the last 8 weeks * Alcohol or drug abuse * Pregnancy * Concurrent systemic disease and/or laboratory abnormalities considered by investigators to be a risk or that could interfere with data collection
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Crohns disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
McMaster University
RECRUITINGHamilton, Ontario, L8N 3Z5, Canada
-
McMaster University Medical Centre
NOT_YET_RECRUITINGHamilton, Ontario, L8S 4L8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple hospital checklist could flag hidden malnutrition in kids with IBD
- Green gut check: can ultrasound slash the carbon cost of IBD testing?
- Real-World surgery study aims to improve fistula care
- New Dye-Free colonoscopy could make cancer screening easier for IBD patients
- Hidden mineral shortage: new study targets magnesium in gut patients
- Real-World study tracks how IBD patients choose between IV and injectable vedolizumab